{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:06Z","timestamp":1790638626760,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jneuroim.2026.578911","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:06:30Z","timestamp":1773504390000},"page":"578911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advances in Parkinson's disease management using umbilical cord-derived mesenchymal stem cells"],"prefix":"10.1016","volume":"416","author":[{"given":"Nishant","family":"Mante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Undale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Sanap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Bhonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Kheur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.578911_bb0005","series-title":"Aliakbari hUC MSC\u2013Derived Exosome-Nanoliposome Hybrids on \u03b1-Synuclein Fibrillation and neurotoxicity.pdf","author":"Aliakbari","year":"2024"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277134","article-title":"Exploring the neurogenic differentiation of human dental pulp stem cells","volume":"17","author":"Al-Maswary","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0020","first-page":"1","article-title":"Bioactive molecules derived from umbilical cord mesenchymal stem cells","author":"Bai","year":"2016","journal-title":"Acta Histochem."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0025","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.18295\/squmj.2018.18.03.002","article-title":"Sources and clinical applications of mesenchymal stem cells state-of-the-art review","volume":"18","author":"Berebichez-Fridman","year":"2018","journal-title":"Sultan Qaboos Univ. Med. J."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/bab.1006","article-title":"Biotechnology and large-scale production of human mesenchymal stem cells for clinical","volume":"59","author":"Biochemistry A","year":"2012","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578911_bb0035","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4103\/1673-5374.211201","article-title":"Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons","volume":"12","author":"Boroujeni","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"July","key":"10.1016\/j.jneuroim.2026.578911_bb0040","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25082000","article-title":"Induced pluripotent stem cell (iPSC)-based neurodegenerative disease models for phenotype recapitulation and drug screening","volume":"25","author":"Chang","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/psb.1804","article-title":"Darvadstrocel for the treatment of complex perianal fistulas","volume":"30","author":"Chaplin","year":"2019","journal-title":"Prescriber"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.apjtm.2015.07.022","article-title":"Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins","volume":"8","author":"Chen","year":"2015","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0060","series-title":"Clinical Potential and Current Progress of Mesenchymal Stem Cells for Parkinson\u2019s Disease: A Systematic Review","author":"Chen","year":"2020"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0075","series-title":"Enhanced Secretion of Hepatocyte Growth Factor in Human Umbilical Cord Mesenchymal Stem Cells Ameliorates Pulmonary Fi Brosis Induced by Bleomycin in Rats","first-page":"1","author":"Chen","year":"2023"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123047","article-title":"The potential therapeutic effect of human umbilical cord mesenchymal stem cell-derived exosomes in bronchopulmonary dysplasia","volume":"357","author":"Cheng","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0963689719891134","article-title":"The effect of human umbilical cord mesenchymal stromal cells in protection of dopaminergic neurons from apoptosis by reducing oxidative stress in the early stage of a 6-OHDA-induced Parkinson\u2019s disease model","volume":"28","author":"Chi","year":"2019","journal-title":"Cell Transplant."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578911_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson\u2019s disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/246134","article-title":"Comparative evaluation of human mesenchymal stem cells of fetal (Wharton\u2019s jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy","volume":"2013","author":"Christodoulou","year":"2013","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040612","article-title":"Review treatment options for motor and non-motor symptoms of Parkinson\u2019s disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0105","first-page":"178","article-title":"Lipid, protein, and MicroRNA composition within mesenchymal stem cell-derived exosomes","volume":"20","author":"Deng","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3727\/096368915X686841","article-title":"Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy","volume":"24","author":"Ding","year":"2015","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"issue":"s1","key":"10.1016\/j.jneuroim.2026.578911_bb0120","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease \u2014 repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0015","first-page":"e938519-1","article-title":"Autophagy and its association with genetic mutations in Parkinson disease","volume":"28","author":"Erekat,","year":"2022","journal-title":"Int. Med. J. Exp. Clin. Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0130","first-page":"181","article-title":"Stem cells and cell therapies in lung biology and diseases: conference report","volume":"12","author":"Fomby","year":"2010","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578911_bb0135","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.biochi.2013.06.028","article-title":"Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations","volume":"95","author":"Fraga","year":"2013","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-020-00106-y","article-title":"Challenges and translational considerations of mesenchymal stem\/stromal cell therapy for Parkinson\u2019s disease","volume":"5","author":"Fri\u010dov\u00e1","year":"2020","journal-title":"npj Regener. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2005-0053","article-title":"Conversion of human umbilical cord mesenchymal stem cells in Wharton\u2019s jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism","volume":"24","author":"Fu","year":"2006","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0155","series-title":"Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical Cord","first-page":"195","author":"Gang","year":"2011"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109505","article-title":"Huc-MSCs-derived exosomes attenuate neuropathic pain by inhibiting activation of the TLR2\/MyD88\/NF-\u03baB signaling pathway in the spinal microglia by targeting Rsad2","volume":"114","author":"Gao","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0165","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/bit.25582","article-title":"Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process","volume":"112","author":"Heathman","year":"2015","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0170","first-page":"93","article-title":"Regenerative medicine in organ and tissue transplantation: shortly and practically achievable?","volume":"6","author":"Heidary Rouchi","year":"2015","journal-title":"Int. J. Organ Transplant. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-03050-4","article-title":"The potential use of mesenchymal stem cells and their exosomes in Parkinson\u2019s disease treatment","volume":"13","author":"Heris","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0180","first-page":"1","article-title":"Dopamine receptors and Parkinson\u2019s disease","volume":"2011","author":"Hisahara","year":"2011","journal-title":"Int. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/14653249.2010.509578","article-title":"Stem cell-like properties of human umbilical cord lining epithelial cells and the potential for epidermal reconstitution","volume":"13","author":"Huang","year":"2011","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0190","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s13311-020-00964-w","article-title":"Approaches to disease modification for Parkinson\u2019s disease: clinical trials and lessons learned","volume":"17","author":"Hung","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0195","first-page":"92","article-title":"Detection of MicroRNAs in extracellular vesicles secreted by umbilical cord-derived mesenchymal stem cells","volume":"37","author":"Huyen","year":"2021","journal-title":"VNU J. Sci. Nat. Sci. Technol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0200","article-title":"Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols","volume":"2014","author":"Ikebe","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101865","article-title":"Transplanted Wharton\u2019s jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson\u2019s disease","volume":"110","author":"Jalali","year":"2020","journal-title":"J. Chem. Neuroanat."},{"issue":"October 2020","key":"10.1016\/j.jneuroim.2026.578911_bb0210","article-title":"Therapeutic effects of Wharton\u2019s jelly-derived mesenchymal stromal cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson\u2019s disease","volume":"113","author":"Jalali","year":"2021","journal-title":"J. Chem. Neuroanat."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0215","first-page":"1173","article-title":"Neuroprotective effects of Wharton\u2019s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson\u2019s disease","volume":"24","author":"Jalali","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0225","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy","volume":"14","author":"Jin","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9140541","article-title":"Therapeutic effects of CUR-activated human umbilical cord mesenchymal stem cells on 1-Methyl-4-phenylpyridine-induced Parkinson\u2019s disease cell model","volume":"2016","author":"Jinfeng","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0235","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13770-022-00450-8","article-title":"A comprehensive cancer-associated MicroRNA expression profiling and proteomic analysis of human umbilical cord mesenchymal stem cell-derived exosomes","volume":"19","author":"Jothimani","year":"2022","journal-title":"Tissue Eng. Regener. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bib721","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/term.504","article-title":"Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson\u2019s disease","volume":"7","author":"Kang","year":"2013","journal-title":"J. Tissue Eng. Reg. Med."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0240","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbmt.2019.08.029","article-title":"A phase 3 randomized study of Remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease","volume":"26","author":"Kebriaei","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0245","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/10428190500215076","article-title":"Bone marrow-derived mesenchymal stem cells","volume":"46","author":"Kemp","year":"2005","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0250","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0255","doi-asserted-by":"crossref","first-page":"887","DOI":"10.33594\/000000180","article-title":"Inflammatory microenvironment of acute myocardial infarction prevents regeneration of heart with stem cells therapy","volume":"53","author":"Khodayari","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578911_bb0260","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.3390\/ijms140611692","article-title":"Wharton\u2019s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications","volume":"14","author":"Kim","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0265","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3727\/096368914X685078","article-title":"A high-efficiency induction of dopaminergic cells from human umbilical mesenchymal stem cells for the treatment of hemiparkinsonian rats","volume":"24","author":"Ko","year":"2015","journal-title":"Cell Transplant."},{"issue":"April","key":"10.1016\/j.jneuroim.2026.578911_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.04.002","article-title":"The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine","volume":"46","author":"L","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0275","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/NDT.S2013","article-title":"Potential cellular and regenerative approaches for the treatment of Parkinson\u2019s disease","volume":"4","author":"Lane","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578911_bb0280","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s11064-010-0211-6","article-title":"Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson\u2019s disease","volume":"35","author":"Li","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0285","series-title":"Human Umbilical Cord-Derived Mesenchymal Stem Cells Differentiate into Epidermal-like Cells Using a Novel Co- Culture Technique","author":"Li","year":"2014"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0290","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ebiom.2016.04.030","article-title":"EBioMedicine exosome derived from human umbilical cord mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive in fl ammation","volume":"8","author":"Li","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0295","series-title":"Umbilical Cord-derived Mesenchymal Stem Cell Secretome Promotes Skin Regeneration and Rejuvenation: From Mechanism to Therapeutics Xixian","author":"Li","year":"2023"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0300","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.7150\/ijms.87472","article-title":"Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances","volume":"20","author":"Li","year":"2023","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0305","article-title":"Multi - omics evaluation of clinical - grade human umbilical cord - derived mesenchymal stem cells in synergistic improvement of aging related disorders in a senescence - accelerated mouse model","author":"Lian","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0310","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jcyt.2014.05.018","article-title":"Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure","volume":"16","author":"Liu","year":"2014","journal-title":"J. Cytotherapy"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0315","first-page":"1","article-title":"The effects of human umbilical cord mesenchymal stem cell transplantation on female fertility preservation in mice","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578911_bb0320","doi-asserted-by":"crossref","first-page":"750","DOI":"10.5966\/sctm.2012-0072","article-title":"Enabling technologies for cell-based clinical translation development and characterization of a clinically compliant Xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells","volume":"1","author":"Lucas","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0325","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/157488812804484611","article-title":"Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC","volume":"7","author":"Lv","year":"2012","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"June","key":"10.1016\/j.jneuroim.2026.578911_bb0330","article-title":"Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis","volume":"74","author":"Ma","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0335","series-title":"Dopaminergic Induction of Umbilical Cord Mesenchymal Stem","author":"Maghsoudi","year":"2016"},{"issue":"15","key":"10.1016\/j.jneuroim.2026.578911_bb0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/0113894501312703240826070530","article-title":"Trends on novel targets and nanotechnology-based drug delivery system in the treatment of Parkinson\u2019s disease: recent advancement in drug development","volume":"25","author":"Majumdar","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jneuroim.2026.578911_bib722","doi-asserted-by":"crossref","first-page":"114701","DOI":"10.1016\/j.intimp.2025.114701","article-title":"Disease microenvironment preconditioning: An evolving approach to improve therapeutic efficacy of human mesenchymal stromal cells","volume":"157","author":"Mante","year":"2025","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0345","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13287-025-04577-y","article-title":"Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson\u2019s disease clinical trial","volume":"16","author":"Martinez-Lemus","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"Pt 1","key":"10.1016\/j.jneuroim.2026.578911_bb0350","article-title":"The neuroprotective effect of human umbilical cord MSCs-derived secretome against \u03b1-synuclein aggregates on the blood-brain barrier","volume":"304","author":"Marzookian","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0355","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2012.03.004","article-title":"Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson\u2019s disease","volume":"246","author":"Mathieu","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep21404","article-title":"Time related variations in stem cell harvesting of umbilical cord blood","volume":"6","author":"Mazzoccoli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0365","series-title":"Human Umbilical Cord-derived Mesenchymal Stem\/Stromal Cells: A Promising Candidate for the Development of Advanced Therapy Medicinal Products","first-page":"1","author":"Mebarki","year":"2021"},{"issue":"21","key":"10.1016\/j.jneuroim.2026.578911_bb0370","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/cells12212565","article-title":"Investigation using human brain organoids and different routes of in vivo administration","volume":"12","author":"Mendes-pinheiro","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0375","series-title":"Umbilical Cord Mesenchymal-Stem-Cell-Derived Exosomes","author":"Meng","year":"2023"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0380","doi-asserted-by":"crossref","first-page":"625","DOI":"10.32598\/bcn.2021.973.3","article-title":"Transdifferentiation of human umbilical cord-derived mesenchymal stem cells in dopaminergic neurons in a three-dimensional culture","volume":"13","author":"Moayeri","year":"2022","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0385","series-title":"Direct Reprogramming of Somatic Cells to Neurons: Pros and Cons of Chemical Approach","first-page":"1330","volume":"Vol. 46","author":"Mollinari","year":"2021"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0390","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i11.4784","article-title":"The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy","volume":"11","author":"Moy","year":"2023","journal-title":"Med. Res. Arch."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","article-title":"Recent advances in drug therapy for Parkinson\u2019s disease","volume":"62","author":"Murakami","year":"2023","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0400","first-page":"1","article-title":"Isolation, cultivation, and characterization of human mesenchymal stem cells isolation of MSC from different tissue sources","volume":"Cd","author":"Mushahary","year":"2017","journal-title":"Cytometry"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0405","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J. Stem Cells"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J. Stem Cells."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0415","series-title":"Isolation and Culture of Dental Pulp Stem Cells from Permanent and Deciduous Teeth","author":"Naz","year":"2019"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM198402233100802","article-title":"\u201cOn\u2013off\u201d phenomenon in Parkinson\u2019s disease","volume":"310","author":"Nutt","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0425","first-page":"1","article-title":"Optimization of human mesenchymal stem cell manufacturing: the effects of animal\/xeno-free media","author":"Oikonomopoulos","year":"2015","journal-title":"Nat. Publ. Gr."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578911_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0435","first-page":"1","article-title":"Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review","author":"Panchalingam","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0440","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/cyto.a.21092","article-title":"CD133 positive progenitor endothelial cell lines from human cord blood","volume":"79","author":"Paprocka","year":"2011","journal-title":"Cytom. Part A J. Int. Soc. Anal. Cytol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0445","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1021\/nn507149w","article-title":"Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species mediated death of implanted cells for cardiac repair","volume":"9","author":"Park","year":"2015","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578911_bb0450","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4103\/1673-5374.387976","article-title":"Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"19","author":"Park","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"January","key":"10.1016\/j.jneuroim.2026.578911_bb0455","article-title":"Neuroscience applied research progress of cell treatment strategy in Parkinson\u2019s disease","volume":"3","author":"Peng","year":"2024","journal-title":"Neurosci. Appl."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0460","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-024-03830-0","article-title":"Umbilical cord blood derived cell expansion: a potential neuroprotective therapy","volume":"15","author":"Penny","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0465","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s12015-011-9256-4","article-title":"Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson\u2019s disease","volume":"7","author":"Pereira","year":"2011","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0470","first-page":"850","article-title":"Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson\u2019s disease","volume":"51","author":"R.","year":"1998","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8837654","article-title":"Mesenchymal stem\/progenitor cells: the prospect of human clinical translation","volume":"2020","author":"Rady","year":"2020","journal-title":"Stem Cells Int."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0480","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0490","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/1673-5374.350193","article-title":"Combined cell-based therapy strategies for the treatment of Parkinson\u2019s disease: focus on mesenchymal stromal cells","volume":"18","author":"Rodr\u00edguez-Pallares","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0495","first-page":"793","article-title":"Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study","author":"Rosy","year":"2015","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578911_bb0500","article-title":"Brain sciences Parkinson\u2019s disease: a narrative review on potential molecular mechanisms of sleep disturbances, REM behavior","volume":"13","author":"Samizadeh M ali","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1010399","article-title":"Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells","volume":"13","author":"Sarsenova","year":"2022","journal-title":"Front. Immunol."},{"issue":"8064","key":"10.1016\/j.jneuroim.2026.578911_bb0510","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578911_bb0515","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.28582","article-title":"Allogeneic bone marrow-derived mesenchymal stem cell safety in idiopathic Parkinson\u2019s disease","volume":"36","author":"Schiess","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0520","first-page":"34","article-title":"Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn\u2019s disease: results from the global ADMIRE-CD II phase 3 study","volume":"19","author":"Serclova","year":"2024"},{"issue":"29","key":"10.1016\/j.jneuroim.2026.578911_bb0525","doi-asserted-by":"crossref","first-page":"20590","DOI":"10.18632\/oncotarget.25020","article-title":"Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: a multicenter prospective study","volume":"9","author":"Servais","year":"2018","journal-title":"Oncotarget"},{"issue":"May","key":"10.1016\/j.jneuroim.2026.578911_bb0530","article-title":"Biological characteristics of umbilical cord mesenchymal stem cells and its therapeutic potential for hematological disorders","volume":"9","author":"Shang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578911_bb0535","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"HHS public access","volume":"54","author":"Sharma","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0540","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbin.10029","article-title":"Dopaminergic cells, derived from a high ef fi ciency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson\u2019s disease rodent model","volume":"37","author":"Shetty","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0545","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3349\/ymj.2005.46.2.260","article-title":"Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion","volume":"46","author":"Shin","year":"2005","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0550","first-page":"49","article-title":"Culture and identification of endothelial progenitor cells from human umbilical cord blood","volume":"3","author":"Song","year":"2010","journal-title":"Int. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0555","article-title":"Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: current Status and novel therapeutic approaches","volume":"11","author":"Status C","year":"2022","journal-title":"Cells"},{"issue":"January","key":"10.1016\/j.jneuroim.2026.578911_bb0560","first-page":"1","article-title":"Human umbilical cord mesenchymal stem cells improve locomotor function in Parkinson\u2019s disease mouse model through regulating intestinal microorganisms","volume":"9","author":"Sun","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"June","key":"10.1016\/j.jneuroim.2026.578911_bb0565","article-title":"The prospective role of mesenchymal stem cells in Parkinson\u2019s disease","volume":"127","author":"Tambe","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"issue":"15","key":"10.1016\/j.jneuroim.2026.578911_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158196","article-title":"Emerging hiPSC models for drug discovery in neurodegenerative diseases","volume":"22","author":"Trudler","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.681087","article-title":"Direct neuronal reprogramming: bridging the gap between basic science and clinical application","volume":"9","author":"Vasan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0580","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson\u2019s disease: a pilot clinical study","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020118","article-title":"Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson\u2019s disease?","volume":"8","author":"Vila\u00e7a-Faria","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0595","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/stem.2224","article-title":"Mesenchymal stromal cells for treatment of acute steroid-refractory graft versus host disease: clinical responses and long-term outcome","volume":"34","author":"Von Dalowski","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0600","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cbf.3204","article-title":"Study of differentiated human umbilical cord \u2013 derived mesenchymal stem cells transplantation on rat model of advanced parkinsonism","volume":"February","author":"Wang","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0605","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4636397","article-title":"Curcumin-activated mesenchymal stem cells derived from human umbilical cord and their effects on MPTP-mouse model of Parkinson\u2019s disease: a new biological therapy for Parkinson\u2019s disease","volume":"2020","author":"Wang","year":"2020","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123014","article-title":"Treatment of Parkinson\u2019s disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF","volume":"356","author":"Wang","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0615","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03499-x","article-title":"Human umbilical cord - derived mesenchymal stem cells ameliorate perioperative neurocognitive disorder by inhibiting inflammatory responses and activating BDNF \/ TrkB \/ CREB signaling pathway in aged mice","volume":"14","author":"Wei","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578911_bb0620","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","article-title":"Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson\u2019s disease","volume":"24","author":"Weiss","year":"2006","journal-title":"Stem Cells"},{"issue":"JUN","key":"10.1016\/j.jneuroim.2026.578911_bb0625","first-page":"1","article-title":"The necrobiology of mesenchymal stromal cells affects therapeutic efficacy","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578911_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biot.201600732","article-title":"Differences in stem cell processing lead to distinct secretomes secretion\u2014implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction","volume":"12","author":"Wernly","year":"2017","journal-title":"Biotechnol. J."},{"issue":"April","key":"10.1016\/j.jneuroim.2026.578911_bb0635","first-page":"1","article-title":"From vial to vein\u202f: crucial gaps in mesenchymal stromal cell clinical trial reporting","volume":"10","author":"Wiese","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0640","series-title":"Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury: Mechanisms, Current Advances and Future Challenges","first-page":"1","author":"Xia","year":"2023"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0645","first-page":"1","article-title":"Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis","author":"Xie","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0650","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2902074","article-title":"The role of the Notch signaling pathway in the differentiation of human umbilical cord-derived mesenchymal stem cells","volume":"29","author":"Xing","year":"2024","journal-title":"Front. Biosci. Landmark"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578911_bb0655","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbmt.2010.06.004","article-title":"Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats","volume":"16","author":"Xiong","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0660","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/gt.2010.152","article-title":"VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson\u2019s disease","volume":"18","author":"Xiong","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0665","series-title":"Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells","first-page":"1214","author":"Yang","year":"2023"},{"issue":"5858","key":"10.1016\/j.jneuroim.2026.578911_bb0670","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2026.578911_bb0675","article-title":"Distrib dopaminergic Signal basal ganglia its Relatsh to Mot Disabil Park Dis","volume":"83","author":"Zhai","year":"2023","journal-title":"Neurobiology"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578911_bb0680","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10561-021-09973-1","article-title":"Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation","volume":"23","author":"Zhang","year":"2022","journal-title":"Cell Tissue Bank."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578911_bb0685","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/1673-5374.368300","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson\u2019s disease and neuronal damage through inhibition of microglia","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578911_bb0690","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/1673-5374.368300","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson\u2019s disease and neuronal damage through inhibition of microglia","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0695","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.2147\/IJN.S550390","article-title":"Biological nanotherapeutics derived from human umbilical cord mesenchymal stem cells: mechanisms and translational potential in multisystem therapies for regeneration and oncology","volume":"20","author":"Zhang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578911_bb0700","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11064-015-1816-6","article-title":"Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson\u2019s disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons","volume":"41","author":"Zhao","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2026.578911_bb0705","first-page":"1","article-title":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease","volume":"4","author":"Zhao","year":"2019"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578911_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12071334","article-title":"Antioxidants improve the proliferation and efficacy of hUC-MSCs against H 2 O 2 -induced senescence","volume":"12","author":"Zheng","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578911_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578911_bb0720","first-page":"89","article-title":"Origin and clinical applications of neural crest-derived dental stem cells","volume":"21","author":"Zhu","year":"2018","journal-title":"Chin. J. Dent Res."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:36:12Z","timestamp":1777937772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":146,"alternative-id":["S0165572826000597"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578911","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Parkinson's disease management using umbilical cord-derived mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578911"}}